A pt (b)(6) was enrolled in (b)(6) study for stress urinary incontinence.On (b)(6) 2010, the pt was injected with 2.0 ml coaptite, lot 1018370.On (b)(6) 2012, the pt developed urinary tract infection identified through urinalysis.On (b)(6) 2012, the pt was treated with antibiotic ciprofloxacin 250mg po bid.The adverse event resolved on (b)(6) 2013.Per physician, the event was of mild severity and probably not related to coaptite.On (b)(6) 2013, the pt developed urinary tract infection reported by a pt.On (b)(6) 2013, the pt was treated with an antibiotic macrobid 100 mg po q12hrs x 10m days.The adverse event resolved on (b)(6) 2013.Per physician, the event was of mild severity and probably not related to coaptite.
|
At the time of this report, the urinary tract infections have resolved.The device history records for the reported lots were reviewed, all required testing specs were met prior to release, there were no abnormalities noted.
|